Navigation Links
Logical Therapeutics Announces Positive Results of LT-NS001 vs. Naproxen Clinical Study
Date:10/27/2009

Bio-activated Prodrug Demonstrates Significant Reduction in Incidence of GI Ulcers and Erosions

SAN DIEGO, Oct. 27 /PRNewswire/ -- Logical Therapeutics, Inc., a Waltham, MA-based biopharmaceutical company announced today the positive results of a Phase I/II clinical trial evaluating the gastrointestinal (GI) safety of its investigational drug LT-NS001, the first of a new class of bio-activated prodrugs being developed for the chronic treatment of arthritic conditions. In the study, subjects receiving LT-NS001 experienced a 78 percent reduction in the rate of gastric ulcers, and fewer gastric and duodenal erosions, when compared with subjects receiving Naprosyn(®) (naproxen). The LT-NS001 prodrug is unique among non-steroidal anti-inflammatory drugs (NSAIDs) as it is pharmacologically inactive as a COX inhibitor in the GI tract, but once absorbed into the bloodstream, it is converted rapidly to naproxen. LT-NS001 has been engineered to reduce the GI safety risks associated with NSAIDs. Results were announced here at the American College of Gastroenterology's (ACG) Annual Scientific Meeting and presented by Jay L. Goldstein, MD, FACG, Professor of Medicine at the University of Illinois at Chicago, who was the lead investigator for the study.

"The positive results of this study challenge the conventional wisdom regarding NSAID-induced gastrointestinal injury, which physicians generally believe can be driven by systemic exposure to the drug. This study demonstrates that a novel mechanism for NSAID therapy, namely a bio-activated prodrug technology, can provide a significant level of improvement in GI safety, and that may be surprising to many physicians," said Peter A. Lankau, Chief Executive Officer of Logical Therapeutics. "This study brings us one step closer to fulfilling a significant unmet medical need for an NSAID with an improved GI toxicity profile and we look forward to continuing the clinical development of LT
'/>"/>

SOURCE Logical Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. S*BIO to Develop New JAK-2 Inhibitor for Treatment of Myeloproliferative Disorders and Hematological Malignancies
2. Biological Psychiatry Publishes Study Showing VYVANSE Demonstrated Significant Efficacy for Treatment of ADHD for up to 12 Hours After Administration
3. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
4. Neurobiological Technologies, Inc. and Buck Institute Partner to Develop Novel Treatment for Alzheimers Disease
5. Nventa Announces Positive Interim Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial
6. Fifth DSMB Meeting Supports Neurobiological Technologies Continuation of Phase 3 Stroke Trials With Viprinex(TM) (ancrod)
7. Nventa Announces Additional Positive Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial
8. Neurobiological Technologies, Inc. Presents Dosing Rationale for Viprinex(TM) (ancrod) at the European Stroke Conference
9. Indevus Presents Successful Phase III NEBIDO(R) Data at American Urological Association
10. Cryoablation Is Focus of 17 Clinical Studies at American Urological Association Annual Meeting
11. TARGETED GENE DELIVERY IN VIVO: Rexin-G Monotherapy Reveals Significant Biological Activity Without Toxicity in Chemo-Resistant Metastatic Breast Cancer (ASCO 2008)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... W.Va. , July 23, 2014 /PRNewswire-iReach/ -- The ... a new five-state Quality Innovation Network-Quality Improvement Organization (QIN-QIO) ... Medical Institute (WVMI). Effective August 1, WVMI ... West Virginia , Pennsylvania ... Jersey and Louisiana.  The Network will engage ...
(Date:7/23/2014)... 23, 2014 Creekridge Capital, an independent ... new vendors so far in 2014 to their ... vendors are from both the healthcare and technology ... large, well-known multi-national companies. Each of these new ... financing products including: standard leasing products, subscription solutions, ...
(Date:7/23/2014)... 2014  When it comes to welcoming our new robot ... roll out the red carpet. Healthcare is one ... 9000-like robots into our human sphere. With healthcare concerns top ... need to apply new technologies to help with old problems. ... robotics is expected to increase from $1.7 billion now to ...
Breaking Medicine Technology:Announcing a New Regional Approach to Medicare Quality Improvement 2Creekridge Capital Signs Several New Vendor Partners 2
... Aug. 26 The Oregon Tourism Commission,launched its ... Program,(Q Care) this week on http://www.OregonQCare.com ., ... created to support the tourism and,hospitality industry through ... customer service, the training will equip,employees with tools ...
... Semafore Pharmaceuticals Inc.,announced data presented at the ... Washington, D.C., showing additional antiangiogenic,activity of vascular-targeted PI3 ... Bv8 signaling., PI3K is part of a ... been shown to play a major role in ...
Cached Medicine Technology:Oregon Tourism Commission Unveils New Online Customer Service Training Program 2SF1126, Semafore's PI3 Kinase Inhibitor, Found to Block Angiogenic Signaling From Both VEGF and Bv8 in Multiple Cell Lines 2SF1126, Semafore's PI3 Kinase Inhibitor, Found to Block Angiogenic Signaling From Both VEGF and Bv8 in Multiple Cell Lines 3
(Date:7/23/2014)... China,s Northwest Agricultural and Forestry University in Shaanxi province, ... memorandum of agreement that lays the groundwork for establishing ... China. , The signing ceremony was held in the ... officials of the U.S. Department of Agriculture and China,s ... a landmark event for UC Davis and for our ...
(Date:7/23/2014)... 2014 Thousands of DePuy Pinnacle hip ... a federal multidistrict litigation underway in U.S. District Court, ... to an Order dated July 18th, U.S. District Judge ... of a $1,000 fee for the preservation and return ... other things, the Order noted that there is no ...
(Date:7/23/2014)... PA (PRWEB) July 23, 2014 Four ... have been lauded in the latest ranking of the ... Report . Released online today and slated for ... Guide recognizes Allegheny General Hospital (AGH), Forbes Hospital, Saint ... medical centers across multiple clinical specialties. , ...
(Date:7/23/2014)... Amy Norton HealthDay Reporter ... timing of a girl,s first menstrual period may be determined ... study suggests. Researchers have identified over 100 regions ... -- a woman,s first menstrual period. The researchers hope these ... of diseases ranging from type 2 diabetes to breast cancer. ...
(Date:7/23/2014)... Ticket Down is a reputable ... at Michigan Stadium . One of the most anticipated ... held at the Big House in Ann Arbor. Michigan Stadium, ... home to a game between Manchester United from the English ... will be held on August 2nd and could be the ...
Breaking Medicine News(10 mins):Health News:Global food safety research agreement signed by China and UC Davis 2Health News:Global food safety research agreement signed by China and UC Davis 3Health News:DePuy Pinnacle Hip Lawsuits Move Forward, as Federal Judge Denies Hospital Bid for $1000 Explant Fee, Bernstein Liebhard LLP Reports 2Health News:DePuy Pinnacle Hip Lawsuits Move Forward, as Federal Judge Denies Hospital Bid for $1000 Explant Fee, Bernstein Liebhard LLP Reports 3Health News:DePuy Pinnacle Hip Lawsuits Move Forward, as Federal Judge Denies Hospital Bid for $1000 Explant Fee, Bernstein Liebhard LLP Reports 4Health News:Four Allegheny Health Network Hospitals Named High Performers by U.S. News 2Health News:Four Allegheny Health Network Hospitals Named High Performers by U.S. News 3Health News:Gene Study Gives New Insight Into Puberty in Girls 2Health News:Gene Study Gives New Insight Into Puberty in Girls 3Health News:Real Madrid vs. Manchester United Tickets Ann Arbor: Ticket Down Slashes Ticket Prices for ManU vs. Real Madrid Guinness International Champions Cup Tickets 2Health News:Real Madrid vs. Manchester United Tickets Ann Arbor: Ticket Down Slashes Ticket Prices for ManU vs. Real Madrid Guinness International Champions Cup Tickets 3
... country of Tanzania were more likely to stop taking ... to pay for the drugs themselves. , According the ... and Duke University Medical Center researchers, HIV-infected patients who ... fare better. , Our findings suggest that efforts to ...
... may have solved the mystery surrounding the healing properties of ... gold salts as a treatment for rheumatoid arthritis and other ... in the early 1900s to ease the pain and swelling ... cost: The shots took months to take effect and ...
... TORONTO, Oct. 22 /PRNewswire/ - IntelliPharmaCeutics Ltd. ... to its generic drug,commercialization activities. In ... that the Company,s operating,affiliate IntelliPharmaCeutics Corp. ("IntelliPharmaCeutics") ... Drug Administration for the filing of,IntelliPharmaCeutics, generic ...
... MRSA on Contact, LAS VEGAS, Oct. ... (Website: http://www.skinvisible.com ) has formulated,a product ... of the Super-Bug, MRSA,(methicillin-resistant Staphylococcus aureus) in ... antibacterial hand sanitizer lotion made,with Invisicare(R), is ...
... of Federal Pre-Emption in Riegel v. Medtronic, Inc., ... the Advanced Medical Technology Association,(AdvaMed) filed a joint amicus ... of Riegel v. Medtronic, Inc. arguing that the FDA ... The brief states that,no other legislative or regulatory entity ...
... of Plastic Surgeons Donates Helmets to Local Public,Schools, ... of,Plastic Surgeons (ASPS) will donate 2,000 multi-sport helmets ... prevent facial injuries and,fractures. The event will be ... Thursday, October 25, from 10:00 - 11:30 a.m., ...
Cached Medicine News:Health News:Clues to ensuring anti-HIV drugs are taken in Africa 2Health News:Clues to ensuring anti-HIV drugs are taken in Africa 3Health News:Scientists discover how gold eases pain of arthritis 2Health News:IntelliPharmaCeuitics Ltd. Announces Generic Drug Commercialization Activities 2Health News:Future MRSA Outbreaks in Schools are Preventable! 2Health News:Future MRSA Outbreaks in Schools are Preventable! 3Health News:Amicus Brief Filed with U.S. Supreme Court in Riegel v. Medtronic, Inc. 2Health News:Children of Baltimore Get Free 'Helmets 4 Safety' 2Health News:Children of Baltimore Get Free 'Helmets 4 Safety' 3
Exactech's AcuMatch C-Series (cemented femoral stem) is designed to provide solutions to the problems which compromise both the short and long term successful outcome of cemented hip arthroplasty....
The uncemented hip joint prosthesis system....
The proximally modular S-ROM Total Hip System provides custom capability at non-custom prices and is competitive with conventional porous coated systems....
The Natural-Hip combines the surgical simplicity of a straight stem with many of the best features of an anatomic stem....
Medicine Products: